Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, September 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
PerkinElmer Launches LabChip® GX and GXII Touch™ Systems
Thursday, July 10, 2014
New automated platform provides life sciences researchers with precise nucleic acid quantification and protein characterization.

ChromaTrap™ Helps Advance Research into Women`s Reproductive Health
Wednesday, July 09, 2014
Latest research developments in women’s reproductive health using molecular biology tools.

OGT Launches High-Resolution, High-throughput PGS Array
Wednesday, July 09, 2014
Confident genome-wide aneuploidy detection in 14 samples on a single array.

Bioo Scientific Launches NEXTflex Cell Free DNA-Seq Kit
Friday, July 04, 2014
Optimized for ctDNA and cfDNA library preparation.

Olink Bioscience Introduces a 92-protein Biomarker Panel
Wednesday, July 02, 2014
Proseek® Multiplex Inflammation I 96x96 for inflammatory diseases.

SciGene Introduces Dual Temperature FISH Slide Incubator
Tuesday, July 01, 2014
CytoBrite Duo Slide Incubation system for performing FISH hybridization protocols.

GE Healthcare Launches Cytell™ Cell Imaging System
Wednesday, June 25, 2014
Streamlines data acquisition, analysis and visualization.

New XFp Analyzer from Seahorse Bioscience
Wednesday, June 25, 2014
Makes measuring metabolism affordable for every lab.

VolitionRx Sells First NuQ® Research Use Only Kits to Active Motif
Tuesday, June 24, 2014
First revenues from VolitionRx Nucleosomics technology.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 2518
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv